FHLC - Fidelity MSCI Health Care Index ETF
|Ex-Dividend Date||Mar 19, 2021|
|Trading Day||April 16|
|Day's Range||60.94 - 61.35|
|52-Week Range||46.38 - 61.35|
The investment seeks to provide investment returns that correspond, before fees and expenses, generally to the performance of the MSCI USA IMI Health Care 25/50 Index. The fund invests at least 80% of assets in securities included in the fund's underlying index. The fund's underlying index is the MSCI USA IMI Health Care 25/50 Index, which represents the performance of the health care sector in the U.S. equity market. It may or may not hold all of the securities in the MSCI USA IMI Health Care 25/50 Index. The fund is non-diversified.
|Asset Class |
|Inception Date |
Oct 21, 2013
|Ticker Symbol |
|Index Tracked |
MSCI USA IMI Health Care Index
Top 10 Holdings40.75% of assets
|Johnson & Johnson||JNJ||7.88%|
|Thermo Fisher Scientific||TMO||3.43%|
|Mar 19, 2021||$0.201||Mar 24, 2021|
|Dec 18, 2020||$0.234||Dec 23, 2020|
|Sep 18, 2020||$0.176||Sep 23, 2020|
|Jun 19, 2020||$0.173||Jun 24, 2020|
|Mar 20, 2020||$0.254||Mar 25, 2020|
|Dec 20, 2019||$0.093||Dec 26, 2019|
Some biotech and pharmaceutical ETFs are gaining on Tuesday despite news that Johnson and Johnson's coronavirus vaccine has been halted in over two dozen states, after the Food and Drug Administration r...
The healthcare is expected to witness substantial earnings growth of 5.1% in the third quarter, representing the second strongest sector this earnings season.
The healthcare sector is expected to witness substantial earnings decline of 6.9% in the second quarter, representing the second strongest sector this earnings season.
With earnings surprise in the cards, the healthcare sector is expected to witness substantial earnings growth of 4.4% in the fourth quarter, suggesting some room for potential upside for healthcare ETFs.
The Vanguard Health Care ETF (VHT) and other healthcare ETFs have been trading higher amid news that U.S. health officials may finally have a potential discovery in the vaping illness outbreak that’s ki...
With earnings surprise in the cards, the healthcare sector is expected to witness modest earnings growth of 0.3% in the third quarter, suggesting some room for potential upside for healthcare ETFs.
With earnings surprise in cards, the healthcare sector is expected to witness earnings growth of 1.7% in the second quarter, suggesting continued outperformance for healthcare ETFs.
Biotech stocks fall after Trump promises executive order drug prices
CNBC's Meg Tirrell reports on the dip in biotech stocks after President Donald Trump promised that an executive order on drug prices is coming.
Health care's sharp drop comes as investors worry that left-leaning policy ideas like universal health coverage are gaining support.